This document discusses perioperative infection control and the role of anesthesiologists. It begins with the epidemiology of healthcare-associated infections and surgical site infections, noting their impact and common causative pathogens. The pathophysiology of the inflammatory response to surgical tissue damage is described. Risk factors for surgical site infections are outlined. The document then reviews the microbiology of surgical site infections and the role of anesthesiologists in controlling various infection prevention measures like hand hygiene, environmental disinfection, and aseptic techniques for procedures. Guidelines for optimizing infection control in the operating room anesthesia work area are also summarized.
Antibiotics for surgical prophylaxis.
Surgical site infections(SSIs) are a significant cause of morbidity and mortality.
Approximately 2% to 5% of patients undergoing clean extra-abdominal operations and 20%undergoing intra-abdominal operations will develop an SSI.
SSIs have become the second most common cause of nosocomial infection and these data are likely underestimated.
Presented by Dr. Hall at the 40th Annual Symposium "Diagnostic and Clinical Challenges of 20th Century Microbes", held on Nov 18, 2010 in Philadelphia.
Antibiotics for surgical prophylaxis.
Surgical site infections(SSIs) are a significant cause of morbidity and mortality.
Approximately 2% to 5% of patients undergoing clean extra-abdominal operations and 20%undergoing intra-abdominal operations will develop an SSI.
SSIs have become the second most common cause of nosocomial infection and these data are likely underestimated.
Presented by Dr. Hall at the 40th Annual Symposium "Diagnostic and Clinical Challenges of 20th Century Microbes", held on Nov 18, 2010 in Philadelphia.
According to the National Center for Health Statistics, approximately 46 million surgical procedures are performed annually in the United States, the majority of which are done in an outpatient setting.1
Infection is the most common complication of surgery.2
Surgical site infections (SSIs) occur in approximately 3% to 6% of
patients and prolong hospitalization by an average of 7 days at a direct annual cost of $5 to $10 billion.3,4
SSIs are the third (14%–16%) most frequent cause of nosocomial infections among hospitalized patients.3
Infection occurs within 30 days after the operative procedure if no implant is left in place or within 1 year if implant is in place and the infection appears to be related to the operative procedure
risk factors includes
Age
Obesity
Diabetes
Malnutrition
Prolonged preoperative stay
Infection at remote site
Systemic steroid use
Nicotine use
According to the National Center for Health Statistics, approximately 46 million surgical procedures are performed annually in the United States, the majority of which are done in an outpatient setting.1
Infection is the most common complication of surgery.2
Surgical site infections (SSIs) occur in approximately 3% to 6% of
patients and prolong hospitalization by an average of 7 days at a direct annual cost of $5 to $10 billion.3,4
SSIs are the third (14%–16%) most frequent cause of nosocomial infections among hospitalized patients.3
Infection occurs within 30 days after the operative procedure if no implant is left in place or within 1 year if implant is in place and the infection appears to be related to the operative procedure
risk factors includes
Age
Obesity
Diabetes
Malnutrition
Prolonged preoperative stay
Infection at remote site
Systemic steroid use
Nicotine use
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
perioperative infection control.pptx
1. Perioperative infection control and
wound healing: Role of
anesthesiologist
Moderator
Dr. Nishkarsh Gupta Dr. Hitender Gautam
Additional Professor Associate Professor
Deptt. of OAPM Deptt. of Microbiology
Dr. Brajesh Ratre
Assistant Professor
Deptt. of OAPM
Presenter- Dr. Gitartha Goswami
SR, Deptt. of OAPM
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
2. Highlights
• Epidemiology
• Pathophysiology
• SSIs and Wound infection
• Microbiology
• Risk factors
• Role of anesthesiologists
• Guidelines and evidences
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
3. Epidemiology
• Incidence of HCAI- developed countries- 3.5–12%, developing countries-
5.7%- 19.1%.
• The risk of HCAI in the OR is even higher.
• SSIs- 2nd most common cause of HCAIs after UTI, account for approximately
17% of all HCAI.
• SSIs are the most common perioperative infection, 38% of all infections in
surgical patients
• Prolongs hospital stay, cause morbidity, increase the cost of health care, and
lead to mortality
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
4. Pathophysiology
• Tissue damage leads to the release of damage activated molecular patterns
(DAMPs) or alarmins into the circulation, eg- HMGB 1, mtDNA
• DAMPs activates pattern recognition receptors (PRRs), also independently
activate complement, neutrophils, monocytes and dendritic cells.
• Activation of PRRs → secretion of cytokines and chemokines via signalling
pathways involving NF-kB.
• Excess production of inflammatory mediators (ILs) leads to SIRS.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
5. Pathophysiology
• SIRS is associated with a compensatory increase in anti-inflammatory
cytokines (IL-10, TGF-β).
• The balance of proinflammatory (IL-6, TNF-a) and antiinflammatory factors
dictates whether inflammation return to baseline or progress to persistent
inflammation, immunosuppression, and catabolism syndrome (PICS).
• PICS increases risk of MODS and sepsis.
• Paradoxically, SIRS suppresses body’s ability to mount a defence against
invading pathogens.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
6. Pathophysiology
• Increased susceptibility to infection and sepsis, invading microbes further
stimulate immune cells via pathogen-associated molecular patterns
(PAMPs).
• A vicious cycle ensues, SIRS results in inflammation and immunoparesis,
which, in turn, leads to sepsis with furthur inflammation and risk of MODS.
• The initial complement activation leads to consumption of complement, an
imbalance ensues, rendering the host susceptible to invading pathogens.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
7. Pathophysiology
• The transfusion of blood and products along with anesthetics contribute to
this immunosuppressive environment.
• Anaesthesia suppresses the immune system, both directly and indirectly.
• Cancer recurrence and infection are intimately linked, both flourish in an
environment of T-cell exhaustion and lymphocyte anergy, observed in the
perioperative period.
• The key concern is the creation of a protumour and proinfection cytokine
and inflammatory milieu.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
8. Pathophysiology
• Natural killer cells, are suppressed by both anaesthetics and opioids.
• Anaesthetics mediate secondary effects through altered adrenocortical
function.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
9. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
10. SSIs
• CDC defines SSI- infection related to an operative procedure that occurs at
or near the surgical incision within 30 days of the procedure or within 90
days if prosthetic material is implanted.
• All surgical wounds are likely to become contaminated, usually by resident
bacterial flora.
• May not be significant and contaminated wounds may go unnoticed.
• Progression from wound contamination to clinical infection is determined
by the adequacy of host defence.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
11. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
8-10% 12-20% 25%
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
12. SSIs types
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
14. MICROBIOLOGY
• Pathogens depend upon the type of wound
• Clean procedures- skin flora, including streptococcal
species, Staphylococcus aureus, and CONS.
• Clean-contaminated procedures- gram-negative and enterococci in
addition to skin flora.
• Surgical procedure involves a viscus, the pathogens reflect the
endogenous flora of the viscus or nearby mucosal surface; typically
polymicrobial.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
15. MICROBIOLOGY
• The causative pathogens associated with SSIs have changed over time.
• SSIs caused by gram-negative bacilli decreased, with emergence MRSA.
• MRSA associated were higher mortality rates, longer hospital stays, and
higher costs.
• During the past decade the proportion of SSI due to MRSA declined.
• Fungal SSIs- widespread use of prophylactic and empiric antibiotics,
increased severity of illness, and immunocompromised patients.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
16. MICROBIOLOGY
• Exogenous sources of contamination- OR environment or
personnel.
• Anal, vaginal, or nasopharyngeal carrier of group A streptococci by
OR personnel, led to several SSI outbreaks.
• Gram-negative organisms is commonly seen on the hands with
artificial nails.
• Rare outbreaks or clusters of SSIs caused by unusual pathogen-
traced to contaminated dressings, bandages, irrigants, or
disinfection solution
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
17. RISK FACTORS FOR SSI
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
18. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
19. Why cancer patients are at increased risk?
• Effects of Cancer
- Impaired cellular and humoral immunity
- Bone marrow infiltration
• Effects of CT/RT
- Disruption of skin and mucosal barriers
- Neutropenia/impaired neutrophil function
• Functional hyposplenism or asplenia after HSCT
• Poor nutritional status, TPN
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
20. What is the role of anesthesiolgist?
• Role both outside and inside the OR.
• Infection prevention in the OR anesthesia work area is important
but very challenging owing to the work flow of anesthesia
providers.
• Policies and procedures for HH, safe injection practises, and
environmental cleaning and disinfection.
• Individuals involved in these procedures require training, as well as
regular skills assessments.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
21. Factors controlled by anesthetists
Hand hygiene
Aseptic technique during invasive
procedures
Face masks and sterile barriers
OR characteristics- Limit traffic
through operating room, Use of
laminar airflow
Surgical antibiotic prophylaxis
Glycaemic control
Perioperative thermoregulation
Perioperative drugs management
Inspired oxygen concentration
Perioperative fluid management
Minimizing blood transfusions
ERAS
Nutrition
Anesthetic technique
- Avoidance of selected drugs
- Regional anaesthesia techniques
- Effect of PPV
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
22. Factors controlled by Surgeon and Surgical techniques
1. Skin antisepsis, Hair removal
2. Bowel preparation
3. Gentle traction
4. Effective hemostasis
5. Removal of devitalized tissues
6. Minimization of electrocautery to avoid thermal spread
7. Obliteration of dead space
8. Irrigation of tissues with saline to avoid excessive drying
9. Wound closure without tension
10. Judicious use of closed suction drains
11. Topical and local antibiotic delivery
12. Antibiotic-impregnated implants, antibiotic sutures
13. Wound dressings, wound protectors
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
23. Guidelines
• Several guidelines available regarding prevention of SSI- CDC, WHO,
APSIC, IDSA, NICE.
• SHEA Expert Guidance on Infection prevention in the operating
room anesthesia work area.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
24. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
25. Infection prevention in the OR anesthesia
work area
• Contamination in the anesthesia work area include the anesthesia cart,
stopcocks, LMAs, laryngoscope blades, touchscreens, keyboards,
providers’ hands.
• Anesthesia work area bioburden- both commensal and pathogenic
bacteria, including CONS, Bacillus spp, streptococci, Staph aureus,
Acinetobacter spp etc.
• High risk practises- use of multi-dose vials for >1 patient, <100% use of
gloves during airway management, failure to perform HH after removing
gloves, entry into anesthesia cart drawers without performance of HH.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
26. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
27. Hand hygiene
• Ideally performed according to the WHO 5 Moments for Hand Hygiene.
• HH performed- before aseptic tasks, after removing gloves, when hands are
soiled or contaminated, before touching the contents of the anesthesia cart,
and when entering and exiting the OR.
• Indications in the OR can be as high as 54/hr, logistically unfeasible, leading to
non adherence rates of 83%,.
• Increasing access to ABHR led to an increase in HH practises by anesthesiology
staff during a surgical procedure
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
28. Hand hygiene
• ABHR dispensers at the entrances to ORs and near anesthesia providers.
• Double gloves during airway management, removal of outer gloves
immediately after airway manipulation and inner gloves ASAP and
perform HH.
• Current data inadequate to either support or discourage use of ABHR on
gloved hands, application might be better when doffing and donning are
not feasible
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
29. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
30. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
31. ASEPTIC PRECAUTIONS FOR VARIOUS
PROCEDURES AND USE OF PPE
• Objective- reduce endogenous and exogenous sources of infection to patients
and HCWs.
• Indications for aseptic practices-
1. During care and nursing of patients : Barrier nursing
2. During therapeutic procedures: i.m. injections, CVP line access, Arterial lines.
3. During airway and endoscopic procedures: Intubation, mechanical
ventilation, suctioning, Bronchoscopy.
4. During various diagnostic procedures
5. Others- foley’s catheterization.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
32. USE OF PERSONAL PROTECTIVE
EQUIPMENT
• Use of PPE appropriate for the procedure.
• PPE interrupt the chain of transmission of organisms from the patient to the
HCW and from the HCW to the patient.
• Correct donning and doffing practises.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
33. OR Environmental disinfection
• Direct laryngoscope or video-laryngoscope handles and blades should
undergo high-level disinfection or sterilization prior to use.
• Otherwise, replace with single-use ones.
• Clean blades and handles to be stored in packaging appropriate for
semicritical items.
• Infectious disease outbreaks have been associated with contaminated
laryngoscopes.
• Laryngoscope handles not able to undergo high-level disinfection should
not be used.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
34. OR Environmental disinfection
• Inadequate data to make recommendations regarding the use of disposable
covers to prevent contamination of anesthesia machines.
• High-touch surfaces on the anesthesia machine and anesthesia work area
should be disinfected between OR uses.
• Use EPA-approved hospital disinfectant that is compatible with the
equipment and surfaces.
• Reusable monitoring equipment and cables in physical contact with patients
should be cleaned.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
35. OR Environmental disinfection
• i.v. access ports- disinfected before each use, scrubbing the port with a
sterile alcohol-based disinfectant or use sterile isopropyl alcohol
containing caps to cover ports continuously.
• The act can be challenging in anesthesia practice, particularly during
induction and emergence of anesthesia.
• Maximal sterile barrier precautions- All CVCs and axillary and femoral
arterial lines.
• Other peripheral arterial lines- a minimum of a cap, mask, sterile gloves,
and a small sterile fenestrated drape.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
36. OR Environmental disinfection
• Rubber stoppers of vials and necks of ampules- wiped with 70%
alcohol prior to use.
• Bacterial contamination of medication syringes can occur with skin
microorganisms.
• Needleless syringes should be capped with a sterile cap that
completely covers the Luer connector on the syringe
• Storage of supplies on the top surface of the cart should be
avoided, should be removed between cases to facilitate cleaning.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
37. OR Environmental disinfection
• Provider-prepared sterile injectable drugs should be used as soon as
practicable, USP recommends use within 1hr
• Commercially prefilled syringes or syringes prepared by the hospital
pharmacy have a relatively long life.
• Discard provider-prepared sterile injectable drugs and i.v. solutions at the
end of each case, whether used or not.
• Unused prefilled syringes with intact locks can be returned to stock.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
38. OR Environmental disinfection
• Use Single-dose medication vials and flushes whenever possible.
• Multi-dose vials- used for only 1 patient and accessed with a new sterile
syringe and needle for each entry.
• Syringes and needles are single patient devices and should never be
reused for another patient.
• Both CDC and AAGBI have issued safe injection practices.
• Minimize the time between spiking IV bags and patient administration.
• No specific time limit has been identified in the literature.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
39. OR Environmental disinfection
• Computer keyboards and touchscreen- cleaned and disinfected after each
anesthesia case using a hospital-approved disinfectant.
• Use of Plastic keyboard shields, or washable keyboards and touchscreens
facilitate thorough disinfection.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
40. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
41. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
42. OR ventilation
• Laminar flow allows particle-free air movement over the aseptic operating
field at a uniform velocity (vertically or horizontally).
• Reduces the burden of microorganisms in the OR during implantation of
prosthetic material
• However, insufficient evidence supporting its routine use
• A systematic review that included 12 observational studies (between 1987
and 2011) did not find any benefit in reducing the incidence of deep
incisional SSI following hip and knee arthroplasty, and abdominal/open
vascular surgeries.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
43. Order of patients
• Common routes for transmission of infection in the OR are airborne or
fomite borne.
• Accurate printed theatre lists to be available prior to the scheduled date.
• ‘Dirty cases’ should be identified beforehand, theatre staffs notified and
scheduled last on an operating list.
• If not possible, Hospital Infection Society advises that a plenum-ventilated
OR should require a minimum of 15 min before proceeding to the next case.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
44. Order of patients
• Appropriate cleaning of the OR between all patients should be
undertaken.
• Visible contamination with blood or body materials disinfected with
sodium hypochlorite and then cleaned with detergent and water.
• Floors of the OR should be disinfected at the end of each session.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
45. Implementation
• Regular monitoring and evaluation of infection prevention
practices.
• Use of measures to improve performance.
• Both overt and covert observation of behaviors can improve
practice.
• Regular feedbacks, surveillance measures.
• Interventions like checklists and simulation for education and
evaluation of different aspects of anesthesia practice
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
46. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
47. Surgical antibiotic prophylaxis
CDC WHO IDSA
Timing In a way that bactericidal
concentration of the
agents is established in
the serum and tissues
when the incision is
made
within the 120 min
before the incision,
while considering the
half-life of the
antibiotic (cefazolin,
penicillins)
Within 1 hour,
2 hours for
Vancomycin and
Fluoroquin.
Repeat
doses
No statement At intervals of 2 half-
lives or if there is
excessive blood loss
At intervals of 2
half-lives
• Postoperatively, CDC recommends antibiotic therapy to continue only in
contaminated and dirty cases.
• Antibiotic stewardship programmes should be practised.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
48. Glycaemic control
• Surgery causes a neuroendocrine stress response with release of counter-
regulatory hormones (Epi, glucagon, cortisol, GH).
• Hyperglycaemia increases risk of morbidity and mortality, even in non-
diabetics.
• DM increases susceptibility to infection by altering both the innate and the
adaptive immune systems
• Hyperglycaemia reduces vasodilation, impairs endothelial nitric oxide
generation, decreases complement function, impairs neutrophil
chemotaxis and phagocytosis.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
49. Glycaemic control
• Nonenzymatic glycosylation of Ig, reducing complement fixation and
opsonization of microbes.
• Short-term hyperglycemia increases oxidative stress and systemic
inflammatory responses.
• Also impairs CD8+ T cell mediated immunity.
• Hyperglycaemia alters the critical balance between inflammatory and
antiinflammatory cytokines; increase adverse outcomes.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
50. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
51. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
52. Glycaemic targets
• CDC guidelines advise perioperative glycemic control, and blood glucose
target levels <200 mg/dL in patients with and without DM to prevent SSIs.
• NICE-SUGAR trial demonstrates conventional glucose control (target of
180 mg/dL) had better outcomes (less mortality) than patients managed
with intensive glucose control (target of 81–108 mg/dL).
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
53. Perioperative thermoregulation
• Mild perioperative hypothermia (34°–36°C) is common in surgical patients.
• Heat loss during the first hour of anesthesia- redistribution of core to
peripheral temperature gradients caused by an anesthetic-induced
vasodliation.
• Causes of continued heat loss in the OR are radiation and convection.
• The most effective means of preventing ongoing heat loss are forced air
warming and administration of warmed fluids.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
54. Perioperative thermoregulation
• Complications- increased LOS, increased intraoperative blood loss,
transfusion requirements, adverse cardiac events
• Mild hypothermia also increases incidence of SSIs.
• Hypothermia triggers thermoregulatory vasoconstriction, thereby
decreasing subcutaneous tissue oxygen tension
• The major relation between hypothermia and increased SSI.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
55. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
56. Preop. temp Management
<36°C Active warming in ward
>/=36°C Active warming at least 30 minutes before induction
Begin induction only when temperature is 36.0°C or above
Active warming throughout the intraoperative phase if-
having anaesthesia for more than 30 minutes or
less than 30 minutes and are at higher risk of inadvertent perioperative
hypothermia
Introp. temp Maintain at >/= 36.5°C
Postop. temp
<36°C Warmed using forced-air warming until comfortably warm
NICE guidelines
57. SSIs risk with FAW devices
• The waste air from FAW is not simply benign waste air.
• The waste heat and air escapes from under the surgical drape near the
floor, where it warms the contaminated air near the floor.
• The contaminated warm air forms convection currents that rise along the
sides of the surgical table
• It mobilizes the floor bacteria into the sterile surgical field above the
patient.
• Studies have shown mixed results, larger RCTs needed.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
58. Perioperative drug management
• Immunosuppressive agents like glucocorticoids, MTX, AZT,
cyclosporine, and tacrolimus.
• Glucocorticoids- major concerns are: (1) the risk of SSIs and (2) the
risk of hemodynamic instability (secondary adrenal insufficiency).
• Ideally, the lowest possible dose of glucocorticoids should be used in
the perioperative setting.
• If patients require >10 mg prednisone (or equivalent) daily, it implies
that the disease activity is not adequately controlled and that elective
surgery should be postponed.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
59. Perioperative drug management
• Stopping DMARDs prior to surgery may result in a flare-up of disease
activity, may adversely affect rehabilitation.
• Biologic DMARDs can be continued till day of surgery.
• Non- biologic DMRDs- Stop for atleast 2 weeks each for etanercept
and adalimumab while 6 months for rituximab before elective surgery
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
60. Inspired oxygen concentration
• Postulated to improve the oxidative bactericidal activity of neutrophils.
• Adequate wound PO2 also helps in the development of collagen and
epithelium, instrumental factors in wound healing.
• Evidence that giving 80% FIO2 rather than 30% reduces wound infections
in colorectal surgeries.
• In vitro analysis of neutrophil function reveals that a higher PO2 promotes
the production of reactive oxygen intermediates.
• Current guidelines to prevent SSIs recommend only giving the required
FIO2 to maintain oxygen saturations above 95%.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
61. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
62. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
63. Perioperative fluid management
• Wound healing is critically dependent on adequate perfusion to deliver
oxygen.
• Mild to moderate hypovolemia is well tolerated as interstitial fluid moves
into the intravascular space to preserve cardiac output.
• However, this leaves the subcutaneous tissue relatively hypovolemic.
• The optimal type of fluid (colloid or crystalloid) or strategy of fluid
management (goal directed, liberal, or restrictive) remain controversial.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
64. Perioperative fluid management
• Difficult to assess volume status in both liberal and restrictive strategy
• GDFT has gained evidence for improved outcomes, does not specifically
relate to a reduction in postoperative infection.
• WHO recommednations (2016) on prevention of SSIs- GDFT in intraop.
and postop. period is associated with decreased incidence of SSIs.
• However, restrictive therapy and preoperative GDFT were not associated
with reduction of SSI compared with standard therapy.
• When considering SSIs as endpoint, GDFT may be considered if available.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
65. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
66. Minimizing blood transfusions
• Immunomodulation and immunosuppression (TRIM) are known
consequences of allogeneic blood transfusion.
• The incidence of postoperative bacterial infection is higher in
transfused patients.
• This effect is greater in trauma patients- established fact.
• The effect appears to be dose-related, older units (>2weeks)
• Consider risk benefit ratios before transfusion, use fresh units.
• Platelet transfusions are associated with bacterial sepsis.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
67. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
68. Enhanced recovery after surgery
(ERAS)
• Initiated by Professor Henrik Kehlet in the 1990s
• ERAS or enhanced recovery programs (ERPs) or fast-tracking.
• Initially started for colorectal surgeries, aim to achieve early
recovery after surgery by maintaining preoperative organ function
and reducing the surgical stress response.
• Implemented in other surgeries and has shown a decrease in the
incidence of HAIs.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
69. ERAS
• Goals- maintenance of normal physiology in the perioperative period,
decreasing surgical stress.
• Key principles of the ERAS protocol
pre-operative counselling
preoperative nutrition
avoidance of prolonged perioperative fasting and carbohydrate
loading up to 2 hours preoperatively
standardized anesthetic and analgesic regimens
early mobilization
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
70. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
71. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
72. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
73. Nutrition
• Malnutrition is associated with a number of negative consequences
Increased susceptibility to infection
Poor wound healing
Increased frequency of decubitus ulcers
Overgrowth of bacteria in the gastrointestinal tract
Abnormal nutrient losses through the stool
• Malnutrition leads to immune system dysfunction by impairing
complement activation, bacterial opsonization, and the function of
neutrophils, macrophages, and lymphocytes
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
74. Preoperative nutrition support
• Adequately nourished or mild-to-moderate malnutrition, surgery need not
be delayed for preoperative parenteral or enteral supplementation.
• Patients with severe malnutrition- some benefit from delaying surgery to
be fed only if catabolism is not due to the disease itself.
• Benefit more from enteral than parenteral feeding; TPN increases risk for
infectious complications.
• However, parenteral nutrition was found beneficial in patients with upper
gastrointestinal malignancies and hepatocellular carcinoma.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
75. Postperative nutrition support
• Enteral nutrition (oral or tube feeds) rather than parenteral, whenever
possible.
• Postoperative parenteral nutrition-if return of bowel function is not
anticipated for more than 10 days, severe malnutrition at baseline, or who
have a complicated postoperative course.
• Role for immune-enhancing nutritional supplements(arginine, glutamine,
nonessential fatty acids, branched chain fatty acids), remains unclear.
• There is insufficient high-quality evidence.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
76. Decrease in infectious comlications including pneumonia, sepsis, wound infection,
UTI etc were seen
A 45% reduction on both infectious and non infectious complications were seen.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
77. Anesthetic technique
• Anaesthetic agents
– Iv agents
– Inhalational agents
– Opioids
• The role of Regional anesthesia
• Effect of Positive pressure ventilation.
• Several literature on association of anesthetic technique on cancer
recurrence.
• Perioperative events leading to cancer recurrence may be intimately
related to perioperative infections.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
78. Agent NK cell
no./activity
T-lymphocyte Others
Propofol Increase Do not inhibit Antioxidant effect
Ketamine/
Thiopentone
/ Etomidate
Decrease Decrease T helper cells
Midazolam - - inhibitory efect on innate
immunity,
inhibit neutrophil adhesion by
inhibiting the level of IL-8
Volatile
anesthetics
Decrease Decrease T helper cell
activity
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
79. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
80. Agent NK cell
no./activity
T-lymphocyte Others
Morphine suppresses NK
cell activity
Suppresses T-cell
differentiation,
promotes lymphocyte
apoptosis
Inhibit macrophage activity
Fentanyl Decrease Increase regulatory T
cells
Sufentanil Decrease Increase regulatory T
cells
Inhibits leukocyte migration
Tramadol May have protective effects
on cellular immunity
NSAIDs Reverses NK
cell
suppression
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
81. Role of regional anesthesia
• Reduces perioperative stress response.
• Serum levels of the stress hormone cortisol are lower.
• Reducing the need for opioids or volatile anesthetics,
• Orthopedic knee surgery conducted under neuraxial anesthesia led to a
significant lower postoperative infections compared with general
anesthesia.
• A reduced duration of T-cell anergy and disturbances in T lymphocyte
subsets (Th1 and 2)
• However, high-quality evidence is lacking.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
82. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
83. Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
84. Effect of Positive pressure ventilation
• Positive pressure ventilation appears to impair mucociliary motility in the
airways.
• Stress and shear forces exerted during the cyclic opening and closing of
alveoli result in increased cytokine production and white cell
sequestration, as does over-distension of alveoli
• PPV induce inflammation, decrease surfactant production, VILI.
• May promote translocation of tracheal bacteria into the bloodstream.
• ETT can serve as a conduit between the environment and LRT.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS